Compounds > mitotane
Page last updated: 2024-10-31

mitotane and Neuromuscular Diseases

mitotane has been researched along with Neuromuscular Diseases in 2 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gutierrez, ML1
Crooke, ST1
Lubitz, JA1
Freeman, L1
Okun, R1

Other Studies

2 other studies available for mitotane and Neuromuscular Diseases

ArticleYear
Mitotane (o,p'-DDD).
    Cancer treatment reviews, 1980, Volume: 7, Issue:1

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Animals; Carcinoma; Dogs; Drug Administration Schedule; Dr

1980
Mitotane use in inoperable adrenal cortical carcinoma.
    JAMA, 1973, Mar-05, Volume: 223, Issue:10

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Diabetic Retinopathy; Female; Follow-Up Studies; Gastroi

1973